Ingevity Corp Stock
Price
Target price
€63.50
€63.50
-0.780%
-0.5
-0.780%
€59.20
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Ingevity Corp Stock
The price for the Ingevity Corp stock decreased slightly today. Compared to yesterday there is a change of -€0.500 (-0.780%).
Currently there is a rather positive sentiment for Ingevity Corp with 5 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 59 € is below the current price of 63.5 € for Ingevity Corp, so the potential is actually -7.09%.
Pros and Cons of Ingevity Corp in the next few years
Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ingevity Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ingevity Corp | -0.780% | 3.084% | 14.828% | 110.823% | 27.102% | - | - |
| Barito Pacific Tbk PT | 6.670% | 44.262% | 1.734% | 319.048% | -43.590% | 166.667% | 102.299% |
| PTT Global Chemical -fgn- | 1.110% | 0.552% | 31.884% | 112.617% | 70.093% | -24.793% | -44.172% |
| Braskem Pfd ADR | 0.000% | -0.645% | -21.429% | 6.207% | 27.273% | -55.036% | -76.124% |
Comments
Ingevity (NGVT) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for NGVT provided by MarketBeat
Ingevity (NGVT) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Show more
Ratings data for NGVT provided by MarketBeat
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $64.00 to $70.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for NGVT provided by MarketBeat
News
Investor Builds $6 Million Position in Surging Chemicals Name Beating the S&P 500 by Nearly 40 Points
On February 17, 2026, EVR Research disclosed a new position in Ingevity (NYSE:NGVT), acquiring 100,000 shares worth $5.92 million.
In a U.S. Securities and Exchange Commission (SEC) filing dated


